Has fabricated information misdirected Alzheimer's research for over a decade? Find out this and more in today's PV Roundup podcast.

Dr. Chethan Sathya, the director of Northwell Center of Gun Violence Prevention joins the podcast to discuss the healthcare professionals' role in addressing firearm safety and violence prevention in this PV Roundup specialist spotlight.

What is the new 3-digit number for the National Suicide Prevention Lifeline? Find out this and more in today's PV Roundup podcast.

Drs. Make and Kalhan share their insights on ATS 2022 topics, such as the utility of CT scans versus spirometry in diagnosing COPD and predicting exacerbations, underdiagnosis, and health inequities in minority communities. They will also discuss using symptoms and risk factors versus spirometry in diagnosis, home pulmonary rehab, and the role of wearable technologies.

How effective is the newly authorized Novavax COVID-19 vaccine? Find out this and more in today's PV Roundup podcast.

Dr. David Wohl, an infectious disease specialist from the University of North Carolina School of Medicine, rejoins us to provide his latest insights on topics in infectious diseases including COVID-19, monkeypox and more in this PV Roundup specialist spotlight.

Can the SARS-CoV-2 spike antigen be used as a biomarker for long COVID? Find out this and more in today's PV Roundup podcast.

Pulmononologists, Drs. Ravi Kalhan and Nick Hanania join the podcast to discuss the topic of COPD readmissions including how serious a hospitalization for COPD actually is in terms of morbidity and mortality, appropriate pharmacotherapy, as well as nonpharmacologic treatments such as pulmonary rehab. They also share their thoughts on the importance of an exacerbation prevention strategy, the utility of a pulmonary discharge team, and close follow-up postdischarge.

Pulmononologists, Drs. Ravi Kalhan and Nick Hanania join the podcast to discuss the frequent challenges of caring for patients with COPD that they see their primary care colleagues face. Issues discussed include potential barriers to prompt diagnosis, personalizing treatment regimens to match the patient's needs and disease, and when it is appropriate to refer to a lung specialist.

When will race-based eGFR calculations be eliminated for kidney transplant candidates? Find out this and more in today's PV Roundup podcast.